{
  "docId": "019de071-25c2-72af-a047-b47d3e86c276",
  "docSlug": "cf4915d9030a007285d7f2ca06f3bce1",
  "documentTitle": "Graphite Bio | IPO Presentation Deck | 50 slides",
  "authorId": "graphite-bio",
  "authorName": "Graphite Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 50,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-25c2-72af-a047-b47d3e86c276/3",
  "deckHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276",
  "deckJsonHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276.json",
  "deckAnchorHref": "/decks/019de071-25c2-72af-a047-b47d3e86c276#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.75,
        "x": 0.22,
        "y": 0.55
      },
      "kind": "list",
      "text": "Use of Proceeds: fund clinical development of GPH101 for SCD, GPH201 for XCID, GPH301 for Gaucher disease, discovery programs, and working capital.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d907c169-65f1-4ebd-b09e-9dba91c3f2cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.94,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "table",
      "text": "Issuer: Graphite Bio, Inc.; Ticker / Exchange: GRPH / Nasdaq Global Select Market; Shares Offered: 12,500,000; Filing Range: $15.00 - $17.00; Estimated Gross Proceeds: $200,000,000; Over-Allotment: 15%; Expected Pricing: June 24, 2021",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9318e146-6476-4ff3-90b0-12787d8fd838",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.07,
        "y": 0.05
      },
      "kind": "title",
      "text": "Offering Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9692c87-36a1-47b8-8b30-fc618396cedf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "a28df8fe-b9a5-4221-b09d-b68b32cb83a6",
      "evidence": "table/data: Issuer: Graphite Bio, Inc.; Ticker / Exchange: GRPH / Nasdaq Global Select Market; Shares Offered: 12,500,000; Filing Range: $15.00 - $17.00; Estimated Gross Proceeds: $200,000,000; Over-Allotment: 15%; Expec",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 1,
      "beatId": "c994cfaf-363b-44c5-a47b-1a330366430d",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "The deck begins with a cover page, disclaimer, and appendix data, setting the stage for the presentation.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}